Arcadia Biosciences Inc Cash Flow-to-Debt Ratio
Arcadia Biosciences Inc cash flow-to-debt ratio. Arcadia Biosciences Inc (RKDA) has a Cash Flow-to-Debt Ratio of -0.36x as of December 2025, meaning its operating cash flow of $-861.00K could theoretically repay 0% of its total liabilities ($2.41 Million) in one year. Check RKDA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Arcadia Biosciences Inc (2012–2025)
Cash flow-to-debt ratio of Arcadia Biosciences Inc from 2012 to 2025. Historical debt coverage capacity for Arcadia Biosciences Inc across 14 annual periods. Also explore Arcadia Biosciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Arcadia Biosciences Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Arcadia Biosciences Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Arcadia Biosciences Inc. For the full cash flow conversion analysis, see RKDA cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.97x | $-4.74 Million | $2.41 Million | ▼ -49.2% |
| 2024 | -1.32x | $-9.63 Million | $7.29 Million | ▲ +39.6% |
| 2023 | -2.18x | $-15.29 Million | $7.00 Million | ▼ -25.4% |
| 2022 | -1.74x | $-13.98 Million | $8.02 Million | ▲ +14.3% |
| 2021 | -2.03x | $-25.87 Million | $12.72 Million | ▼ -26.5% |
| 2020 | -1.61x | $-30.22 Million | $18.80 Million | ▼ -126.7% |
| 2019 | -0.71x | $-17.20 Million | $24.25 Million | ▲ +41.7% |
| 2018 | -1.22x | $-13.63 Million | $11.21 Million | ▲ +25.4% |
| 2017 | -1.63x | $-13.96 Million | $8.56 Million | ▼ -228.7% |
| 2016 | -0.50x | $-17.05 Million | $34.38 Million | ▼ -11.7% |
| 2015 | -0.44x | $-15.11 Million | $34.02 Million | ▲ +19.6% |
| 2014 | -0.55x | $-14.79 Million | $26.77 Million | ▼ -52.1% |
| 2013 | -0.36x | $-9.74 Million | $26.84 Million | ▲ +27.9% |
| 2012 | -0.50x | $-9.59 Million | $19.04 Million | — |